Eritadenine | CAS#23918-98-1 | SAHH inhibitor

Eritadenine
featured

WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 598566

CAS#: 23918-98-1

Description: Eritadenine is a potent inhibitor of S-adenosyl-L-homocysteine hydrolase (SAHH), decreasing total cholesterol levels in plasma.

Chemical Structure

Eritadenine

CAS# 23918-98-1

Instruction

Theoretical Analysis

MedKoo Cat#: 598566
Name: Eritadenine
CAS#: 23918-98-1
Chemical Formula: C9H11N5O4
Exact Mass: 253.08
Molecular Weight: 253.210
Elemental Analysis: C, 42.69; H, 4.38; N, 27.66; O, 25.27

Price and Availability

Size	Price	Availability
10mg	USD 400	2 weeks
25mg	USD 880	2 weeks
50mg	USD 1400	2 weeks
Bulk inquiry Welcome, Customer: Please do not inquire quote if your intended use is for a patient since our products are for research use and for chemical synthesis use, not for human use . For in-stock products, we listed price in the web page. You may inquire prices for which sizes were not listed. If no price is listed, this means the product is not in stock at the moment, which may be available via custom synthesis. For cost-effective reason, minimum order of 1g is requested (typically very expensive). The lead time is usually 2-4 months. Quote of less than 1g will not be provided. MedKoo may not offer quote for below reasons: (1) current available synthetic method appears to be extremely expensive which is obviously not affordable to most customers; (2) Key raw material to make the product is temporally not available; (3) DEA controlled substances; (4) the product is under patent protection in customer’s country.

Synonym: Eritadenine; Lentinacin; Lentysine; D-Eritadenine;

IUPAC/Chemical Name: (2R,3R)-4-(6-amino-9H-purin-9-yl)-2,3-dihydroxybutanoic acid

InChi Key: LIEMBEWXEZJEEZ-INEUFUBQSA-N

InChi Code: InChI=1S/C9H11N5O4/c10-7-5-8(12-2-11-7)14(3-13-5)1-4(15)6(16)9(17)18/h2-4,6,15-16H,1H2,(H,17,18)(H2,10,11,12)/t4-,6-/m1/s1

SMILES Code: O=C(O)[C@H](O)[C@H](O)CN1C=NC2=C(N)N=CN=C12

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

More Info:

Instruction:

View handling instruction

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 253.21 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

Mass

Concentration

Volume

M. Wt* g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

Volume (to add to vial)

Mass (in vial)

Desired Reconstitution Concentration

Dilution Calculator

Calculate the dilution required to prepare a stock solution.

Concentration 1

Volume 1

Concentration 2

Volume 2

1: Afrin S, Rakib MA, Kim BH, Kim JO, Ha YL. Eritadenine from Edible Mushrooms Inhibits Activity of Angiotensin Converting Enzyme in Vitro. J Agric Food Chem. 2016 Mar 23;64(11):2263-8. doi: 10.1021/acs.jafc.5b05869. Epub 2016 Mar 14. PubMed PMID: 26938194.

2: Shimada Y, Morita T, Sugiyama K. Eritadenine-induced alterations of plasma lipoprotein lipid concentrations and phosphatidylcholine molecular species profile in rats fed cholesterol-free and cholesterol-enriched diets. Biosci Biotechnol Biochem. 2003 May;67(5):996-1006. PubMed PMID: 12834276.

3: Shimada Y, Yamakawa A, Morita T, Sugiyama K. Effects of dietary eritadenine on the liver microsomal Delta6-desaturase activity and its mRNA in rats. Biosci Biotechnol Biochem. 2003 Jun;67(6):1258-66. PubMed PMID: 12843651.

4: Sugiyama K, Akachi T, Yamakawa A. Hypocholesterolemic action of eritadenine is mediated by a modification of hepatic phospholipid metabolism in rats. J Nutr. 1995 Aug;125(8):2134-44. PubMed PMID: 7643248.

5: Ctrnáctá V, Fritzler JM, Surinová M, Hrdý I, Zhu G, Stejskal F. Efficacy of S-adenosylhomocysteine hydrolase inhibitors, D-eritadenine and (S)-DHPA, against the growth of Cryptosporidium parvum in vitro. Exp Parasitol. 2010 Oct;126(2):113-6. doi: 10.1016/j.exppara.2010.04.007. Epub 2010 Apr 20. PubMed PMID: 20412798; PubMed Central PMCID: PMC2914804.

6: Shimada Y, Morita T, Sugiyama K. Dietary eritadenine and ethanolamine depress fatty acid desaturase activities by increasing liver microsomal phosphatidylethanolamine in rats. J Nutr. 2003 Mar;133(3):758-65. PubMed PMID: 12612149.

7: Fukada S, Setoue M, Morita T, Sugiyama K. Dietary eritadenine suppresses guanidinoacetic Acid-induced hyperhomocysteinemia in rats. J Nutr. 2006 Nov;136(11):2797-802. PubMed PMID: 17056803.

8: Yang H, Hwang I, Kim S, Hong EJ, Jeung EB. Lentinus edodes promotes fat removal in hypercholesterolemic mice. Exp Ther Med. 2013 Dec;6(6):1409-1413. Epub 2013 Oct 8. PubMed PMID: 24255670; PubMed Central PMCID: PMC3829752.

9: Enman J, Rova U, Berglund KA. Quantification of the bioactive compound eritadenine in selected strains of shiitake mushroom (Lentinus edodes). J Agric Food Chem. 2007 Feb 21;55(4):1177-80. Epub 2007 Jan 27. PubMed PMID: 17256958.

10: Sugiyama K, Yamakawa A, Kawagishi H, Saeki S. Dietary eritadenine modifies plasma phosphatidylcholine molecular species profile in rats fed different types of fat. J Nutr. 1997 Apr;127(4):593-9. PubMed PMID: 9109610.

11: Sekiya A, Fukada S, Morita T, Kawagishi H, Sugiyama K. Suppression of methionine-induced hyperhomocysteinemia by dietary eritadenine in rats. Biosci Biotechnol Biochem. 2006 Aug;70(8):1987-91. Epub 2006 Aug 1. PubMed PMID: 16880595.

12: Shimada Y, Morita T, Sugiyama K. Effects of dietary eritadenine on delta6-desaturase activity and fatty acid profiles of several lipids in rats fed different fats. Biosci Biotechnol Biochem. 2002 Jul;66(7):1605-9. PubMed PMID: 12224653.

13: Sugiyama K, Yamakawa A. Dietary eritadenine-induced alteration of molecular species composition of phospholipids in rats. Lipids. 1996 Apr;31(4):399-404. PubMed PMID: 8743052.

14: Enman J, Hodge D, Berglund KA, Rova U. Production of the bioactive compound eritadenine by submerged cultivation of shiitake (Lentinus edodes) mycelia. J Agric Food Chem. 2008 Apr 23;56(8):2609-12. doi: 10.1021/jf800091a. Epub 2008 Mar 26. PubMed PMID: 18363329.

15: Sugiyama K, Yamakawa A, Saeki S. Correlation of suppressed linoleic acid metabolism with the hypocholesterolemic action of eritadenine in rats. Lipids. 1997 Aug;32(8):859-66. PubMed PMID: 9270978.

16: Yamada T, Komoto J, Lou K, Ueki A, Hua DH, Sugiyama K, Takata Y, Ogawa H, Takusagawa F. Structure and function of eritadenine and its 3-deaza analogues: potent inhibitors of S-adenosylhomocysteine hydrolase and hypocholesterolemic agents. Biochem Pharmacol. 2007 Apr 1;73(7):981-9. Epub 2006 Dec 14. PubMed PMID: 17214973.

17: Huang Y, Komoto J, Takata Y, Powell DR, Gomi T, Ogawa H, Fujioka M, Takusagawa F. Inhibition of S-adenosylhomocysteine hydrolase by acyclic sugar adenosine analogue D-eritadenine. Crystal structure of S-adenosylhomocysteine hydrolase complexed with D-eritadenine. J Biol Chem. 2002 Mar 1;277(9):7477-82. Epub 2001 Dec 10. PubMed PMID: 11741948.

18: Schanche JS, Schanche T, Ueland PM, Holý A, Votruba I. The effect of aliphatic adenine analogues on S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase in intact rat hepatocytes. Mol Pharmacol. 1984 Nov;26(3):553-8. PubMed PMID: 6493210.

19: Bisen PS, Baghel RK, Sanodiya BS, Thakur GS, Prasad GB. Lentinus edodes: a macrofungus with pharmacological activities. Curr Med Chem. 2010;17(22):2419-30. Review. PubMed PMID: 20491636.

20: Takashima K, Izumi K, Iwai H, Takeyama S. The hypocholesterolemic action of eritadenine in the rat. Atherosclerosis. 1973 May-Jun;17(3):491-502. PubMed PMID: 4736648.

Your view history

Eritadenine featured